[HTML][HTML] Recombinant human ADAMTS13 treatment and anti-NET strategies enhance skin allograft survival in mice

SL Wong, J Goverman, C Staudinger… - American Journal of …, 2020 - Elsevier
Enhancing skin allograft longevity lessens the need for new allografts before optimal
intervention is available. Reduced activity of ADAMTS13 (an enzyme that cleaves the pro …

[HTML][HTML] Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients

A Bauer, E Pachl, JC Hellmuth, N Kneidinger… - … et Biophysica Acta (BBA …, 2023 - Elsevier
SARS-CoV-2 remains an acute threat to human health, endangering hospital capacities
worldwide. Previous studies have aimed at informing pathophysiologic understanding and …

Adamts13 treatment to enhance graft survival

DD Wagner, SL Wong - US Patent App. 17/765,728, 2022 - Google Patents
The disclosure provides a method for treating and/or pre venting graft rejection with A
Disintegrin And Metallopro teinase with Thrombospondin type 1 motif, member-13 …